Eos Capital’s Investment in Fabupharm’s Operations in Namibia

Lead party: Eos Capital (Pty) Ltd (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Fabupharm Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Ordinary Shares (Equity) · Equity stake: 0.35% · Fund: Eos Capital Allegrow Fund Lead investor/buyer: Eos Capital (Pty) Ltd…


Lead party: Eos Capital (Pty) Ltd (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Fabupharm

Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Ordinary Shares (Equity) · Equity stake: 0.35% · Fund: Eos Capital Allegrow Fund

Lead investor/buyer: Eos Capital (Pty) Ltd · Investors/buyers: Eos Capital (Pty) Ltd

Legal advisers: not identified in the source record.

Source: announced 31 August 2016. Original announcement: eoscapital.com.na.